Table 1.
(a) Raw results of the three software packages assessed on the samples of 185 patients. Any result from a software is considered as a false positive as long as its quantification is at least 1% and it is not detected by the reference method. (b) Corrected results, after taking into account two Sanger sequencing to verify the two FLT3-ITDs detected by two software, and by considering as false positive only FLT3-ITDs detected above 1% by a software in any negative sample
FiLT3r | km | FLT3-ITD-ext | |
---|---|---|---|
(a) | |||
True pos. | 145 | 134 | 144 |
False neg. | 0 | 11 | 1 |
False pos. | 17 | 6 | 9 |
(b) | |||
True pos. | 147 | 136 | 144 |
False neg. | 0 | 11 | 3 |
False pos. | 0 | 0 | 0 |
Precision | 1 | 1 | 1 |
Recall | 1 | 0.93 | 0.98 |
F1 | 1 | 0.96 | 0.99 |